Analysis of the consequences of premature termination codons within factor VIII coding sequences.


Inhibitor antibody formation is a complication of factor VIII (FVIII) replacement therapy due to a failure to synthesize sufficient FVIII protein to induce immune tolerance. The incidence of nonsense mutations in inhibitor patients is high, however, this association is variable according to the position of the mutation. We have studied the effect of… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.